
NNNN P/E Ratio
P/E Ratio as of Jun 13, 2025: 142.90
Average133.67
Median131.31
Minimum124.42
Maximum145.21
142.90
Past Month+19.80 (16.08%)
The P/E ratio for NNNN is 142.90 as of Jun 13, 2025. This represents a increase of 360.23% compared to its 12-month average P/E ratio of 31.05. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Anbio Biotechnology Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Anbio Biotechnology Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Anbio Biotechnology Ltd to industry peers.
Anbio Biotechnology Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Anbio Biotechnology Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Anbio Biotechnology Ltd to industry peers.
NNNN P/E Ratio Insights
See Anbio Biotechnology Ltd’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in NNNN
Order type
Buy in
Order amount
Est. shares
0 shares
NNNN P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $7.915 | 130.61 |
May 1, 2025 | $6.29 | 103.80 |
Apr 1, 2025 | $7.27 | 68.20 |
Mar 18, 2025 | $6.90 | 69.98 |
NNNN End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | 142.90 | — |
FAQs About Anbio Biotechnology Ltd (NNNN) P/E ratio
The latest P/E ratio of NNNN is 142.90, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Anbio Biotechnology Ltd’s last 12-month average P/E ratio is 31.05, compared to its current P/E ratio of 142.90. This reflects a increase of 360.23%.
Anbio Biotechnology Ltd’s current P/E ratio of 142.90 is higher than its last 12-month average P/E of 31.05. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Anbio Biotechnology Ltd’s average P/E ratio over the last 3 years is 10.35. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Anbio Biotechnology Ltd’s average P/E ratio over the last 5 years is 6.21. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.